Elite Trades From Anywhere

$100 Off Your First Year

00
Days
00
Hours
00
Mins
00
Sec
Claim Now
Index
-
Market Cap
26.94B
Enterprise Value
33.32B
Income
1.12B
Sales
20.45B
Book/sh
13.79
Cash/sh
3.07
Employees
66401
IPO
Mar 17, 1980
P/E
23.79
Forward P/E
14.10
PEG
2.55
P/S
1.32
P/B
2.01
P/C
9.02
P/FCF
12.26
EV/EBITDA
10.39
EV/Sales
1.63
Quick Ratio
0.90
Current Ratio
1.32
Debt/Eq
0.71
LT Debt/Eq
0.60
Option/Short
Yes / No
EPS (ttm)
1.17
EPS next Y
1.97
EPS next Q
0.40
EPS this Y
-4.92%
EPS next Y
11.29%
EPS next 5Y
5.53%
EPS past 3/5Y
- -4.98%
Sales past 3/5Y
2.42% 0.39%
EPS Y/Y TTM
244.86%
Sales Y/Y TTM
-
EPS Q/Q
113.83%
Sales Q/Q
5.95%
Insider Own
18.96%
Insider Trans
0.00%
Inst Own
5.14%
Inst Trans
-1.34%
ROA
3.69%
ROE
8.70%
ROIC
5.33%
Gross Margin
45.19%
Oper. Margin
9.37%
Profit Margin
5.49%
SMA20
4.05%
SMA50
4.30%
SMA200
-0.74%
Trades
Shs Outstand
952.02M
Shs Float
787.13M
52W High
33.44 -17.03%
52W Low
23.75 16.80%
Volatility
1.15% 1.62%
ATR (14)
0.54
RSI (14)
61.49
Beta
0.73
Rel Volume
0.80
Avg Volume
1.16M
Volume
930,255
Perf Week
1.65%
Perf Month
9.08%
Perf Quarter
1.65%
Perf Half Y
1.28%
Perf YTD
2.44%
Perf Year
13.13%
Perf 3Y
32.26%
Perf 5Y
-38.28%
Perf 10Y
22.65%
Prev Close
27.20
Price
27.74
Change
1.99%
Date Action Analyst Rating Change Price Target Change
Dec-17-25Initiated RBC Capital Mkts Sector Perform
Feb-25-25Upgrade Exane BNP Paribas Neutral → Outperform
Feb-20-25Upgrade UBS Neutral → Buy
Oct-29-24Upgrade Jefferies Underperform → Hold
May-13-24Upgrade Bernstein Mkt Perform → Outperform
May-07-24Upgrade Exane BNP Paribas Underperform → Neutral
Apr-30-24Upgrade UBS Sell → Neutral
Apr-30-24Upgrade JP Morgan Underweight → Neutral
Feb-07-24Downgrade Exane BNP Paribas Outperform → Underperform
Jul-12-23Initiated Goldman Buy
Jun-22-26 05:35PM
Jun-17-26 09:00AM
Jun-09-26 03:25PM
01:07PM
11:25AM
08:55AM Loading…
08:55AM
04:00AM
Jun-04-26 04:00AM
Jun-02-26 09:00AM
09:00AM
04:00AM
May-28-26 09:00AM
May-18-26 11:00AM
10:00AM
04:00AM
09:01AM Loading…
May-08-26 09:01AM
May-06-26 02:53AM
01:27AM
01:00AM
Apr-23-26 06:07PM
09:00AM
Apr-22-26 09:00AM
Apr-17-26 12:51AM
Apr-16-26 05:33PM
09:00AM
Apr-06-26 07:01PM
Apr-02-26 08:00AM
Mar-27-26 06:16AM
Mar-26-26 09:10AM
Mar-25-26 05:00AM
05:00PM Loading…
Mar-24-26 05:00PM
04:30AM
Mar-23-26 05:30AM
04:30AM
Mar-17-26 09:00AM
Mar-11-26 11:00AM
05:45AM
05:29AM
03:33AM
Mar-10-26 11:00AM
Mar-09-26 09:40AM
Mar-06-26 02:47PM
01:25PM
Mar-05-26 09:00AM
Mar-04-26 04:35AM
Mar-03-26 10:15AM
05:09AM
04:00AM
Mar-02-26 10:50AM
Feb-19-26 09:40AM
04:00AM
Feb-17-26 09:50AM
09:35AM
Feb-12-26 09:00AM
Feb-11-26 12:16PM
11:48AM
04:00AM
Feb-10-26 06:44PM
12:25PM
10:01AM
09:41AM
08:18AM
05:27AM
05:27AM
05:24AM
05:09AM
04:04AM
03:13AM
03:01AM
02:18AM
01:00AM
12:55AM
Feb-09-26 07:18AM
Feb-04-26 06:01PM
Feb-03-26 04:00AM
Jan-29-26 01:00PM
Jan-27-26 01:01AM
Jan-23-26 07:48AM
Jan-22-26 10:31AM
Jan-21-26 05:00AM
Jan-16-26 06:07AM
Jan-15-26 09:09AM
05:22AM
Jan-12-26 08:26AM
Jan-07-26 09:40AM
Dec-17-25 06:21AM
Dec-15-25 09:08AM
07:25AM
02:00AM
Dec-04-25 12:28PM
12:21PM
08:11AM
07:14AM
Dec-01-25 08:00AM
Nov-30-25 12:00PM
11:40AM
Nov-24-25 09:00AM
Nov-19-25 09:00AM
Nov-17-25 08:00AM
Nov-04-25 01:30PM
Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment; Connected Care; Personal Health; and Other. The Diagnosis and Treatment segment consists of systems, smart devices, software, and services, powered by AI-enabled solutions that support precision diagnoses and minimally invasive treatment in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care segment focuses on Hospital Patient Monitoring, Sleep and Respiratory Care, and Enterprise Informatics. The Personal Health segment represents Oral Healthcare business unit, Personal Care business unit, and Mother and Child Care business unit. The Other segment is involved on the Innovation and Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.
PresidentMr. Roy W. O. Jakobs
Ph.D.Dr. Paulus A. Stoffels M.D.
Executive VPMs. Charlotte Hanneman
Executive VPMr. Marnix J. van Ginneken Ph.D.
Executive VP & COOMr. Willem Appelo